Topics

Drug that delays, prevents type 1 diabetes granted PRIME designation

05:56 EDT 29 Oct 2019 | SmartBrief

The European Medicines Agency granted Priority Medicines designation to Provention Bio's lead candidate PRV-031, or teplizuma -More

Original Article: Drug that delays, prevents type 1 diabetes granted PRIME designation

NEXT ARTICLE

More From BioPortfolio on "Drug that delays, prevents type 1 diabetes granted PRIME designation"

Quick Search